A Guided Meditation Program in Patients Undergoing Dialysis

Status: Completed
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is an open-label, single center, non-randomized, single-arm pilot study to determine the ability of a Relaxation and Guided Imagery Program for its ability to induce a reduction in anxiety in subjects undergoing hemodialysis for End Stage Renal Disease (ESRD). Measures will evaluate the program's ability to impact anxiety, with secondary analysis of headaches, insomnia, fatigue, and pain. Subjects will be administered questionnaires at the study start and study end. Intervention will involve listening to a pre-recorded guided relaxation and imagery during regularly-scheduled dialysis sessions for four weeks.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Males and females; 18 years or older.

• Receiving hemodialysis at The Rogosin Institute for End Stage Renal Disease.

• Willingness to adhere to the treatment intervention schedule.

• Subjects must present with anxiety.

• Willing and able to provide informed consent.

Locations
United States
New York
The Rogosin Institute
New York
Time Frame
Start Date: 2020-01-06
Completion Date: 2020-10-07
Participants
Target number of participants: 10
Treatments
Experimental: Guided imagery
Relaxation and guided imagery program
Related Therapeutic Areas
Sponsors
Collaborators: Weill Medical College of Cornell University
Leads: The Rogosin Institute

This content was sourced from clinicaltrials.gov